Find Academic Supervisors

• Medical Education
• Mental Health and Psychiatric Practice
• Organizational Development
• +5 more

Dr. Jackie Knight serves as Senior Lecturer in Medical Education at Brighton and Sussex Medical School (University of Brighton), where she directs NHS England-funded multi-professional simulation and fellowship programmes. Her expertise spans medical education, mental health practice, organizational development, and digital learning innovation across healthcare systems. Her educational background includes: PhD in developing change management theoretical frameworks through reflection (mental health perspective) MSc in Education MSc in Healthcare Leadership and Management BSc (Hons) in Health Studies Dr. Knight's research centers on transformative practice models that bridge professional learning, reflective practice, and organizational change. She pioneers simulation-based pedagogy and digital learning hubs to enhance interprofessional collaboration, with recent work scaling family-integrated care models and VR applications for foundation programmes. Her scholarship emphasizes practical implementation within NHS constraints while fostering sustainable workforce development. Analysis of her 2019-2023 publications reveals three dominant trajectories: (1) Digital innovation in medical education (33%), particularly VR simulation and learning hubs; (2) Mental health systems transformation (33%), focusing on threshold concepts and antipsychotic safety; (3) Interprofessional practice scaling (33%), including family-integrated care and communication frameworks. These intersect at the nexus of education theory and clinical implementation. Her recognitions include: Senior Fellowship of the Higher Education Academy (SFHEA) 2023 Canterbury Christchurch University Poster Prize for Cancer Pharmacy Digital Hub As an active supervisor, Dr. Knight provides dissertation guidance at Master's and PhD levels while leading £1.2M+ in active grants. Her NHS England and HEE-funded projects support 75+ healthcare professionals annually through simulation fellowships and leadership development. These initiatives feature embedded research components yielding high-impact publications and service improvements. She directs the Multi-professional Simulation Fellowship programme and Steps for Success initiative, coordinating teams across 12 NHS trusts. Her groups specialize in translating educational theory into practice through co-designed simulation scenarios, digital resource development, and change management frameworks that address real-world clinical challenges in mental health and interdisciplinary care.

Alex KentsisView profile

Assistant Professor

• Functional Proteomics
• Genomic Plasticity
• Childhood Cancer
• +9 more

Alex Kentsis is an Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University. He leads the Kentsis Research Group within the Molecular Pharmacology Program at the Sloan Kettering Institute and the Tow Center for Developmental Oncology. His research focuses on understanding the fundamental causes of childhood and developmental cancers to develop definitive therapies. Dr. Kentsis's research spans several key areas in cancer biology: Functional proteomics and genomic plasticity of refractory childhood cancers Genomic plasticity and somatic DNA transposases and nucleases in developmental cancers Epigenetic signaling and its therapeutic blockade in leukemias and solid tumors High-accuracy mass spectrometry for the discovery and drugging of cancer proteomes His recent publications reveal a strong focus on understanding why young people develop cancer, with particular emphasis on transposase-derived mechanisms like PGBD5 in childhood cancer mutagenesis. His work bridges proteomics, genomics, and epigenetics to develop novel therapeutic approaches for pediatric cancers, especially targeting DNA damage response pathways and epigenetic regulators. Dr. Kentsis has developed computational biology tools such as ProteomeGenerator2 and BarcodeBabel that enable precise, genome-scale proteogenomic analysis. Dr. Kentsis leads a multidisciplinary research group comprising physicians and scientists studying cancers affecting children and young adults, from embryonal tumors in infants to leukemias and brain tumors in children, and sarcomas in young adults. His lab develops innovative approaches for therapeutic drug delivery and proteomic screening to advance cancer treatment.

• Analytical Chemistry
• Food Safety
• Pesticide Residue Analysis
• +5 more

Antonia Garrido Frenich is a Professor in the Department of Chemistry and Physics at the University of Almería, Spain, where she leads the Analytical Chemistry of Contaminants research group. With an impressive publication record of 387 articles, 33 books or chapters, and numerous research projects, she has established herself as a leading expert in analytical chemistry for food safety and environmental monitoring. Her research focuses on developing advanced analytical methods for detecting contaminants in food and environmental samples. Key areas include pesticide residue analysis, plastic additives monitoring, food authenticity verification, and natural toxin detection. She specializes in high-resolution mass spectrometry techniques coupled with chromatographic methods, and has pioneered innovative approaches using green chemistry principles for sample preparation. Professor Garrido Frenich's recent work demonstrates a strong emphasis on emerging contaminants, particularly non-phthalate plastic additives in agricultural environments, and advanced techniques for food safety assessment. Her publications appear consistently in high-impact journals across food science, analytical chemistry, and environmental science disciplines. As an active Principal Investigator, she currently leads significant research projects including 'Analytical strategies for monitoring emerging contaminants derived from plastics in agricultural soils' (2023-2026) and 'NMR-CONTROL' for implementing nuclear magnetic resonance in food analysis laboratories. She has supervised numerous doctoral students and maintains an extensive collaborative network, evidenced by her co-authorship on publications with researchers from multiple institutions. Her work bridges analytical chemistry with practical applications in food safety and environmental protection.

• Analytical Chemistry
• Food Safety
• Environmental Contaminants
• +6 more

Professor Roberto Romero-González is a distinguished researcher in the Department of Chemistry and Physics at the University of Almería, Spain. With an extensive publication record of 257 articles and an h-index of 49 (Scopus), he leads the Analytical Chemistry of Contaminants Research Group and serves as Principal Investigator on multiple national research projects. His research focuses on analytical chemistry with emphasis on food safety and environmental contaminants. Key areas include pesticide analysis, plastic additives determination, natural deep eutectic solvents for green extraction, biopesticide residues, and food authentication. He has developed innovative methodologies using high-resolution mass spectrometry and chromatographic techniques for detecting contaminants in complex matrices. Professor Romero-González's recent publication trends show a strong focus on emerging contaminants, particularly non-phthalate plastic additives in environmental and food samples, and the application of natural deep eutectic solvents for sustainable analytical methodologies. His work spans food safety, environmental monitoring, and method development across multiple high-impact journals. As an educator and mentor, he has supervised numerous PhD and Master's students, with at least 9 theses listing him as director or co-director. His research group provides training in advanced analytical techniques and contributes to solving real-world problems in food safety and environmental contamination. His current research is supported by the project 'Estrategias analíticas para el control de contaminantes emergentes derivados de plásticos en suelos agrícolas' (2023-2026), continuing his long-standing commitment to developing analytical solutions for emerging contaminants in agricultural and food systems.

• Pediatric Oncology
• Neuroblastoma Research
• Cancer Genetics
• +3 more

Professor Deborah Tweddle is a faculty member at Newcastle University specializing in pediatric oncology, with a primary focus on neuroblastoma and related childhood cancers. Her research spans cancer genetics, clinical pharmacology in neonates and infants, and the application of advanced genomic technologies to improve diagnosis and treatment. Her research interests center on the genetic underpinnings of neuroblastoma (particularly ALK aberrations), tumor evolution, and evidence-based dosing guidelines for chemotherapy in infants. She employs techniques such as optical genome mapping, cell-free DNA analysis, and serial tumor sequencing to investigate tumor heterogeneity and identify therapeutic targets, with emphasis on translating genomic findings into clinical applications. Analysis of her 2021-2025 publications reveals consistent focus on neuroblastoma through large collaborative studies including the UK Children's Cancer and Leukaemia Group (UK CCLG) and European Neuroblastoma Study Group (SIOPEN). Her work bridges laboratory research and clinical trials, addressing critical gaps in pediatric pharmacology, tumor genomics, and risk-stratified treatment approaches. No scientific awards were mentioned in the provided text. Professor Tweddle leads major research consortia including UK CCLG and SIOPEN trials, indicating significant grant funding and leadership in multinational studies. While specific grant details are absent, her role in nationwide clinical trials (e.g., BEACON-Neuroblastoma) demonstrates substantial research infrastructure. No student mentoring information appears in the current publication records. She collaborates extensively across UK and European institutions, frequently co-authoring with Newcastle colleagues like Professor Gareth Veal (clinical pharmacology) and Dr. Shelby Barnett, reflecting a team-based approach to advancing neuroblastoma therapeutics through integrated laboratory-clinical frameworks.

Nicole McDonaldView profile

Assistant Clinical Professor

• Autism Spectrum Disorder
• Neurodevelopmental Disorders
• Tuberous Sclerosis Complex
• +4 more

Nicole McDonald, PhD, is an Assistant Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. She is a licensed clinical psychologist specializing in the early identification of Autism Spectrum Disorder (ASD) and serves as an Attending Psychologist at the UCLA Child and Adult Neurodevelopmental (CAN) Clinic. Dr. McDonald conducts ASD-focused evaluations primarily in young children, provides family-based treatment for behavior problems in preschool-aged children using approaches like Parent-Child Interaction Therapy (PCIT), and oversees the clinic practicum program. Her educational background includes: BA in Psychology from University of California, San Diego (2004) PhD in Clinical Psychology from University of Miami (2013) Clinical Psychology Internship at NYU/Bellevue (2013) Postdoctoral Fellowship in Developmental Neuroscience at Yale Child Study Center (2016) Dr. McDonald's research focuses on understanding neurodevelopmental disorders, with particular emphasis on Autism Spectrum Disorder and Tuberous Sclerosis Complex. Her McDonald Lab employs a multidisciplinary approach that integrates brain-based methods such as Electroencephalography (EEG) and functional Near-Infrared Spectroscopy (fNIRS) with naturalistic behavioral assessments to study early social and emotional development in infants at elevated risk for ASD. She is particularly interested in infants with familial risk for ASD and children with genetic conditions like Tuberous Sclerosis Complex. Her current NIH-funded research examines developmental trajectories in high-risk NICU graduates during their first year of life. Dr. McDonald is currently leading several important research initiatives: RAINBOW Study: Remote Assessment and Intervention for Behavior Problems in Kids with Tuberous Sclerosis Complex NESTING Study: Neurodevelopment and Early Social-Emotional Trajectories In NICU Graduates SSRI Study: Examining the relationship between oxytocin and the mother-infant relationship in mothers with and without postpartum depression Her research has significant implications for early identification and intervention strategies for children with neurodevelopmental disorders. Dr. McDonald is also an active member of the Baby Siblings Research Consortium, contributing to large-scale collaborative efforts to understand the early emergence of autism. Dr. McDonald has supervised multiple postdoctoral fellows, research associates, and students who contribute to her lab's work on understanding early social development and implementing evidence-based interventions for at-risk infants and children with neurodevelopmental disorders.

• Obstetrics
• Gynecology
• Maternal Health
• +3 more

Ane Lilleøre Rom serves as an Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with clinical practice anchored at Copenhagen University Hospital (Region Hovedstaden) in Copenhagen. Her dual academic-clinical role focuses on bridging obstetric research with patient care at Blegdamsvej 3, 2200 København N. Her research program centers on migraine disorders during pregnancy, investigating critical intersections between neurological conditions and obstetric outcomes. Key interests include antimigraine medication safety in early gestation, exercise interventions for pregnant migraineurs, migraine subtype impacts on adverse pregnancy events, fetal growth restriction assessment via novel technologies like CentaFlow™, and neonatal implications of early skin-to-skin contact practices. This work addresses significant gaps in maternal-fetal medicine through rigorous clinical epidemiology. Analysis of her 2025 publications reveals methodological consistency in systematic reviews, randomized trials, and cross-sectional designs to evaluate perinatal interventions. Her research demonstrates strong thematic cohesion around evidence-based improvements for migraine-affected pregnancies, with particular emphasis on medication safety protocols and technological innovations in fetal monitoring. These contributions advance clinical guidelines for high-risk obstetric populations while highlighting underexplored areas in pregnancy neurology.

Catharine FlemingView profile

Lecturer

• Public Health Nutrition
• Paediatric Nutrition
• Infant Feeding Practices
• +5 more

Dr. Catharine Fleming is a Lecturer in Public Health at Western Sydney University's School of Science and Health, with additional affiliations at the Centre for Health Research (CHR) and Young and Resilient Research Centre. Previously, she served as a Casual Academic at Western Sydney University (2016-2018) and Researcher at UNSW Sydney (2011-2016). Her research spans public health nutrition with specialization in: Paediatric nutrition and infant feeding practices Maternal-child health interventions Chronic disease and obesity prevention Oncology nutrition in childhood cancer survivors Nutritional interventions in low-middle income countries Her recent publications (2019-2021) demonstrate strong focus on global breastfeeding practices, childhood cancer survivor nutrition, breast screening barriers in high-risk populations, and digital health governance for children. Research consistently addresses health disparities through mixed-methods approaches. Dr. Fleming has secured over $180,000 in external funding and maintains active collaborations examining nutritional challenges across Australia, Bangladesh, and West Africa. Her work informs clinical protocols and public health policies addressing paediatric nutrition in resource-limited settings.

• Neonatal Nursing
• Pediatric Oncology
• Child Health
• +2 more

Dr. Sheeja Perumbil Pathrose serves as a Lecturer in the School of Nursing and Midwifery at Western Sydney University, Australia, with extensive experience teaching undergraduate and postgraduate nursing programs. Her academic work centers on quantitative research methodologies applied to critical healthcare challenges affecting vulnerable infants and children. Her educational background includes: PhD in Nursing, Sri Ramchandra University, Chennai, India Master’s in Nursing (Child Health Nursing), University of Delhi, India Dr. Pathrose's research focuses on neonatal nursing practices, pediatric oncology (particularly adolescent and young adult cancer), and healthcare interventions for vulnerable child populations. She employs rigorous quantitative methods to investigate practical clinical issues, aiming to translate research findings into improved healthcare outcomes for high-risk pediatric patients. Her work emphasizes evidence-based approaches to address systemic challenges in child healthcare delivery. She maintains professional engagement through affiliations including membership in the Australian College of Neonatal Nurses Research Special Interest Group (2017-2018). Current information regarding active grants, student supervision capacity, or laboratory resources is not available in the provided documentation.

Devin W. McBrideView profile

Assistant Professor

• Neuroscience
• Neurosurgery
• Stroke Research
• +5 more

Dr. Devin W. McBride is an Assistant Professor in the Vivian L. Smith Department of Neurosurgery at The University of Texas Health Science Center at Houston (UTHealth Houston), where he joined in 2017. His appointment is within McGovern Medical School, reflecting his clinical and translational research focus in neurological disorders. Dr. McBride earned his PhD in Bioengineering from the University of California, Riverside under the mentorship of Dr. Victor G. J. Rodgers. He completed his postdoctoral training at Loma Linda University under Dr. John H. Zhang, focusing on translational neuroscience research with emphasis on cerebrovascular disease. His research focuses on understanding the pathophysiology of subarachnoid hemorrhage (SAH), particularly delayed cerebral ischemia (DCI), which remains a critical factor in poor patient prognosis. Dr. McBride employs live imaging techniques to study cerebrovascular dynamics following neurological injury, while also investigating thermodynamics and transport phenomena of crowded protein solutions, video bioinformatics, and medical device design with neurological applications. His interdisciplinary approach bridges engineering principles with clinical neuroscience to develop novel therapeutic strategies. Dr. McBride's publication record demonstrates consistent contributions to the fields of cerebrovascular disease, brain injury mechanisms, and neurological device development, with numerous publications in high-impact journals such as PLOS One, Stroke, and Journal of Cerebral Blood Flow & Metabolism. His research often involves collaborative work across multiple institutions. His scientific achievements include: NSF IGERT Fellowship in Video Bioinformatics DOE GAANN Fellowship NIH F32 award from NHLBI to develop and study an animal model of vasovagal syncope Dr. McBride maintains active research in the neurosurgery department, with particular emphasis on identifying patients at high risk for developing delayed cerebral ischemia after subarachnoid hemorrhage and elucidating novel therapeutic targets. His laboratory work combines advanced imaging techniques with translational neuroscience to address critical challenges in neurological care.

Kimberly HillyerView profile

Assistant Professor

• Neonatology
• Genetics
• Nursing
• +3 more

Kimberly Hillyer, DNP is an Assistant Professor at Loma Linda University School of Nursing with expertise spanning neonatology, genomics, and critical care nursing. Her academic journey at Loma Linda University includes an Associate in Science (2000), Bachelor of Science (2001), Master of Science (2006), and Doctor of Nursing Practice (2017). Dr. Hillyer's research focuses on the integration of genomic medicine into neonatal intensive care, with particular emphasis on rapid whole genome and exome sequencing applications for critically ill newborns. Her work bridges the gap between advanced genetic diagnostics and bedside nursing practice, examining how these technologies can accelerate diagnosis and improve treatment decisions in the NICU setting. Analysis of her publication record from 2021-2025 reveals a growing emphasis on genomic applications in neonatal care, with recent articles addressing rapid sequencing implementation, congenital infections, and genetic disorders in premature infants. Her research demonstrates increasing sophistication in translating genomic technologies into practical clinical workflows. Dr. Hillyer currently serves as an investigator on three significant research projects: the CaLI Trial examining surfactant administration methods for preterm infants, a NIH-funded trial comparing umbilical cord milking with delayed cord clamping, and the MINVI trial focused on cord milking in non-vigorous infants. These projects demonstrate her commitment to evidence-based approaches for improving neonatal outcomes through innovative interventions. As an educator and researcher, Dr. Hillyer offers students opportunities to engage with cutting-edge neonatal genomic research and participate in NIH-funded clinical trials. Her work represents an important intersection of nursing science, genomics, and neonatal critical care that is increasingly relevant in modern healthcare.

• Aggressive Interactions
• Early Prevention
• Juvenile Delinquency
• +3 more

Catherine Blatier is a Professor at the University of Grenoble Alpes, France, affiliated with the Clinical and Cognitive Processes Axis. Her academic career spans over 25 years with continuous research output from 1992 to 2016, focusing on the intersection of developmental psychology and criminology. Her research portfolio centers on: Developmental psychology of aggressiveness and aggressive interactions from early childhood through adolescence Prevention strategies for externalizing/internalizing disorders and juvenile delinquency Social and moral judgment development in institutional contexts Cross-cultural comparisons of juvenile justice systems (particularly France-Canada) Gender-specific analyses of delinquent behavior Professor Blatier's publication trajectory shows consistent high-impact output with 15+ publications between 2000-2016, including multiple articles in 2016 alone. Her work demonstrates strong international collaboration, primarily with Canadian researchers, and addresses both theoretical frameworks (moral judgment internalization) and practical applications (recidivism assessment tools). While specific grant details aren't documented, her sustained research activity indicates robust funding support. Her laboratory work within the Clinical and Cognitive Processes Axis provides empirical foundations for early intervention programs targeting aggressive behaviors and delinquency prevention.

• Neonatal Nursing
• Neonatal Intensive Care
• Nursing Education
• +3 more

Maria Adamopoulos is a Lecturer in Nursing at La Trobe University, Australia, holding this position since January 2020. She serves as Neonatal Stream Coordinator for the Master of Nursing (Neonatal Care and Neonatal Special Care) and Subject Coordinator for the third-year subject 'Care of the Neonate with Special Needs' in the Bachelor of Nursing/Bachelor of Midwifery program. Her educational background includes: Postgraduate Certificate in Clinical Teaching from James Cook University (2010) Postgraduate Certificate in Neonatal Intensive Care from La Trobe University (2004) Bachelor of Nursing/Bachelor of Applied Science (Health Promotion) from Deakin University (1997-2000) Her research and teaching expertise centers on neonatal critical care, with emphasis on physiological complications in high-risk infants. Clinical experience as a Neonatal Clinical Nurse Specialist since 2001 directly informs her academic focus on translating specialized care protocols into nursing education. Her 2012 publication in Acta Paediatrica demonstrates investigative work in neonatal cardiology, specifically examining myocardial impacts of pulmonary hypertension. She actively contributes to curriculum development for neonatal specialization pathways and maintains clinical practice at Monash Health's Monash Newborn unit. Proficient in Modern Greek, she engages in cross-cultural healthcare contexts and participates in educational web conferences as a subject-matter expert.

Sathish Kumar NatarajanView profile

Associate Professor

• Nutrition Science
• Maternal-Fetal Health
• Lipotoxicity
• +6 more

Sathish Kumar Natarajan is an Associate Professor in the Department of Nutrition and Health Sciences at the University of Nebraska-Lincoln's College of Education and Human Sciences. His research focuses on developing nutraceutical approaches to mitigate liver and placental lipotoxicity that occurs during acute fatty liver of pregnancy and maternal obesity. He has made significant contributions to understanding how dietary palmitoleate protects against placental complications and Zika virus-induced damage. Dr. Natarajan earned his Ph.D. in Biomedical Sciences from Dr. MGR Medical University in Tamilnadu, India in 2008. Prior to that, he completed an M.S. in Biochemistry (2001) and a B.S. in Biochemistry (1999), both from the University of Madras, Tamilnadu, India. Dr. Natarajan's research program centers on placental biology and nutrient interventions during pregnancy complications. His lab has identified palmitoleate, an omega-7 monounsaturated fatty acid found in foods like macadamia nuts, as a cytoprotective nutrient against placental complications including acute fatty liver of pregnancy, Zika virus infection, and maternal obesity. His work explores how dietary interventions can prevent adverse pregnancy outcomes and fetal complications, with particular focus on the mechanisms of lipotoxicity and viral pathogenesis at the maternal-fetal interface. His research bridges nutrition science, virology, and obstetrics to develop potential nutrient-based therapies for high-risk pregnancies. Analysis of Dr. Natarajan's recent publications reveals a strong focus on lipid metabolism in pregnancy complications, particularly the role of omega fatty acids and their derivatives in maternal-fetal health. His work spans basic science investigations of cellular mechanisms to clinical studies examining nutrient impacts on infant growth and development. A consistent theme is the protective role of specific fatty acids against placental damage, with increasing emphasis on Zika virus interactions and maternal obesity-related complications in his most recent work. Scientific Awards and Recognition 2022: ad hoc reviewer for the Special Emphasis Panel, ZRG1-DKUS-J (06) study section, NIEHS 2021: Topic Editor-in-chief for issue on "Novel Therapeutic Nutrient Molecules" in multiple journals 2021: ESI reviewer for the Hepatobiliary Pathophysiology (HBPP) study section, NIDDK 2018: USDA-NIFA A1343 Study section panelist 2016: Thematic Best Poster Award, American Society for Biochemistry and Molecular Biology 2015: Travel Award to attend American Association for the Study of Liver Disease 2004: Shakuntala Amir Chand Prize, Indian Council of Medical Research Dr. Natarajan has mentored numerous undergraduate and graduate students through the Natarajan Lab, including UCARE students, graduate research assistants, and postdoctoral fellows. His lab members have gone on to pursue diverse careers in medicine, veterinary science, research, and clinical practice. His research has been supported by various funding mechanisms including seed grants from the NU collaborative initiative, and he has collaborated extensively with researchers at UNMC and other institutions. The Natarajan Lab at the University of Nebraska-Lincoln is a multidisciplinary research group focused on placental biology and nutrient interventions during pregnancy. The lab operates as part of the Nebraska Center for Virology and collaborates with the Child Health Research Institute at UNMC. Current research projects include investigating palmitoleate protection against Zika virus, studying the impact of maternal obesity on placental function, and examining genetic defects in fatty acid oxidation enzymes.

Aliyar FouladkhahView profile

Associate Professor

• Antibiotic Resistance
• Antimicrobial Interventions
• Foodborne Bacterial Pathogens
• +9 more

Dr. Aliyar Fouladkhah is an Associate Professor in the Department of Agricultural and Environmental Sciences at Tennessee State University's College of Agriculture. With expertise spanning food microbiology, public health, and climate change impacts on food safety, Dr. Fouladkhah leads research on antimicrobial interventions against foodborne pathogens and serves as a key resource for food safety outreach and education in Tennessee and beyond. Dr. Fouladkhah's educational background includes: PhD in Meat Science and Food Safety (Food Microbiology) from Colorado State University MS in Food Science & Nutrition from Colorado State University Graduate Certificates in Applied Statistics and Data Analysis, and Regulatory Affairs AP MPH in Applied Biostatistics and Epidemiology from Yale University School of Public Health Additional Certificates in Regulatory Affairs and Climate Change and Health from Yale Dr. Fouladkhah's research focuses on critical food safety challenges including antibiotic resistance in changing climate conditions, ecology of planktonic cells and biofilms of foodborne bacteria, and foodborne disease epidemiology. His work examines innovative interventions such as high-pressure processing combined with natural antimicrobials to combat pathogens like Listeria monocytogenes , Salmonella , and Shiga toxin-producing E. coli . His extension work centers on Food Safety Modernization Act (FSMA) compliance and HACCP implementation for small producers and food manufacturers. Analysis of Dr. Fouladkhah's recent publications reveals a strong emphasis on the intersection of food safety, climate change, and public health. His research increasingly addresses how changing environmental conditions impact foodborne pathogen behavior and resistance mechanisms. A significant portion of his work focuses on developing synergistic antimicrobial interventions that combine physical methods like high-pressure processing with natural compounds to enhance food safety while maintaining product quality. Dr. Fouladkhah has received numerous prestigious awards recognizing his contributions to public health and food safety: Excellence in Climate Leadership Award from the Center for Climate Health and Equity of American Public Health Association (2024) APHA Catherine Cowell Award for excellence in public health nutrition (2024) USAID Volunteer of the Year Award (2020) Distinguished Industrial Scientist Award from Tennessee Academy of Science (2022) Outstanding Service Award from Yale Alumni Association (2022) As a principal investigator, Dr. Fouladkhah has secured multiple USDA-NIFA grants totaling over $2 million, with current projects including "Public Health Microbiology and Process Authority Support for Tennessean Entrepreneurs" ($300,000) and as Co-PI on the Southern Regional Center for FSMA Food Safety Training ($990,000). His grant portfolio demonstrates strong alignment between research, extension, and educational initiatives addressing food safety challenges for small producers and processors. Dr. Fouladkhah also serves as a process authority for food manufacturers and regularly provides technical assistance to entrepreneurs. Dr. Fouladkhah leads the Public Health Microbiology Research and Outreach Laboratory at Tennessee State University, which focuses on developing evidence-based interventions against foodborne pathogens. The lab collaborates with industry partners including Pressure BioScience Inc. and has conducted international training programs in countries including Haiti, Jamaica, and Georgia, focusing on building local capacity for food safety testing and implementation of modern food safety practices.